LakeShore Cost Of Revenue vs Operating Income Analysis
| LSBPW Stock | 0.05 0 4.19% |
LakeShore Biopharma financial indicator trend analysis is infinitely more than just investigating LakeShore Biopharma Co, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether LakeShore Biopharma Co, is a good investment. Please check the relationship between LakeShore Biopharma Cost Of Revenue and its Operating Income accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Cost Of Revenue vs Operating Income
Cost Of Revenue vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of LakeShore Biopharma Co, Cost Of Revenue account and Operating Income. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between LakeShore Biopharma's Cost Of Revenue and Operating Income is -0.53. Overlapping area represents the amount of variation of Cost Of Revenue that can explain the historical movement of Operating Income in the same time period over historical financial statements of LakeShore Biopharma Co,, assuming nothing else is changed. The correlation between historical values of LakeShore Biopharma's Cost Of Revenue and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost Of Revenue of LakeShore Biopharma Co, are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Cost Of Revenue i.e., LakeShore Biopharma's Cost Of Revenue and Operating Income go up and down completely randomly.
Correlation Coefficient | -0.53 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Cost Of Revenue
Cost of Revenue is found on LakeShore Biopharma Co, income statement and represents the costs associated with goods and services LakeShore Biopharma provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Operating Income
Operating Income is the amount of profit realized from LakeShore Biopharma Co, operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of LakeShore Biopharma Co, is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from LakeShore Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into LakeShore Biopharma Co, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LakeShore Biopharma Co,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. At this time, LakeShore Biopharma's Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value is likely to climb to about 7.9 B in 2025, despite the fact that Tax Provision is likely to grow to (18.6 M).
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 30.9M | 44.3M | 51.0M | 29.6M | Depreciation And Amortization | 36.7M | 42.2M | 48.5M | 37.9M |
LakeShore Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
LakeShore Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.